Introduction {#sec1}
============

Protein ubiquitination is an important posttranslational modification that affects virtually every cellular process. Its best-studied function is the degradation of proteins by the proteasome ([@bib11]). However, ubiquitination also regulates alternative degradation pathways, such as ER-associated degradation, autophagy, and mitophagy ([@bib6; @bib39]). In addition, ubiquitination has many non-degradative roles in protein kinase signaling, DNA damage response, intracellular trafficking, transcription, and translation ([@bib24]).

During ubiquitination, the 76-amino acid protein ubiquitin (Ub) is attached via its C terminus to, most commonly, Lys residues on substrate proteins. The versatility of Ub in regulating cellular processes arises from its ability to form a wide variety of polyUb chains ([@bib24]). Ub has seven internal Lys residues and an N-terminal amino group, all of which can be ubiquitinated, leading to the formation of polyUb chains. Proteomic analyses have revealed that all Ub chain linkages exist simultaneously in cells ([@bib21; @bib49; @bib52]). Chains can be homotypic, in which only one linkage type is present, but also heterotypic, in which multiple linkages form mixed and branched structures ([@bib24]). Importantly, different linkage types have distinct cellular roles. K48-linked Ub chains are proteasomal degradation signals, whereas K63-linked Ub chains are mainly non-degradative. For the remaining six "atypical" linkage types, cellular roles are less clear. K11-linked chains are important in cell-cycle regulation, where they seem to constitute an alternative proteasomal degradation signal ([@bib50]) but also have other roles ([@bib4]), whereas M1-linked chains have independent non-degradative roles, in particular during NFκB activation and apoptosis ([@bib16]). For the remaining four chain types, linked via K6, K27, K29, and K33, very little is known, and proteins generating and recognizing these chains in eukaryotic cells are still elusive ([@bib26]).

The process of ubiquitination is facilitated by an enzymatic cascade in which an E1 Ub-activating enzyme transfers Ub onto the active-site Cys of an E2 Ub-conjugating enzyme ([@bib38; @bib53]). The E2 enzyme can directly discharge its Ub onto substrates, usually with the help of a RING or U-box E3 ligase ([@bib8]). Alternatively, a subset of E2 enzymes can perform a transthiolation reaction by transferring Ub onto the active-site Cys of a HECT or RBR E3 ligase. When charged with Ub, HECT and RBR E3 ligases modify substrates in an E2-independent manner ([@bib3]). Importantly, a number of E2 enzymes as well as several HECT and RBR E3 ligases are known to assemble polyUb in a linkage-specific fashion ([@bib26; @bib30]). Based on this knowledge, we have previously described enzymatic assembly systems for K11- and K6-linked chains using a modified E2- and a HECT-like E3 ligase, respectively ([@bib5; @bib13]).

When polyUb chains are generated, they are recognized by Ub binding domains (UBDs), some of which bind polyUb chains in a linkage-specific manner ([@bib15]). Linkage-specific UBDs for M1-linked chains have been described (e.g., [@bib36]) but are unknown for the remaining atypical chain types. Deubiquitinases (DUBs) hydrolyze Ub chains, in some cases with linkage preference ([@bib7; @bib25]). Characterization of the ovarian tumor (OTU) DUB family has revealed enzymes to hydrolyze atypical chain types specifically ([@bib19; @bib28; @bib31; @bib32; @bib33]).

In our search for assembly systems of atypical Ub chain types, we confirmed an earlier report showing that UBE3C primarily assembles K29- and K48-linked chains ([@bib55]) and further discovered that the HECT E3 ligase apoptosis-resistant E3 ubiquitin protein ligase 1 (AREL1), also known as KIAA0317 ([@bib22]), assembles atypical K11- and K33-linked chains in autoubiquitination reactions and predominantly K33-linkages in free chains and on reported substrates. Treatment of assembly reactions with linkage-specific DUBs enabled purification of K29- and K33-linked polyUb in quantities suitable for biophysical and structural studies. This enabled the structural characterization of the polymers and of the K29/K33 linkage-specific OTU family DUB TRABID ([@bib28]). DiUb of both linkage types adopt open conformations in solution, similar to K63-linked polyUb. We found that the TRABID N terminus, which contains three Npl4-type zinc finger (NZF) UBDs, specifically binds K29- and K33-linked diUb, and specificity can be attributed to the first NZF domain (NZF1). A crystal structure of NZF1 bound to K33-linked diUb reveals an intriguing filamentous structure for K33 polymers in which NZF1 binds each Ub-Ub interface. A similar binding mode is observed for K29-linkages in solution studies, together suggesting a model for TRABID interaction with atypical chains. Inactive TRABID localizes to Ub-rich puncta in cells, and this is attenuated when the K29/K33-specific binding mode is disrupted by point mutations. Our work unlocks K29- and K33-linked Ub chains for biochemical studies and provides a launching point for future discoveries related to these atypical Ub signals.

Results {#sec2}
=======

HECT E3 Ligases Assemble Atypical Ub Chains {#sec2.1}
-------------------------------------------

The HECT family of E3 ligases contains 28 members, many of which have important cellular functions ([@bib34]). Much research has focused on the first discovered member, E6AP ([@bib37]), and on the NEDD4 family, which comprises Rsp5 in yeast and nine enzymes in humans ([@bib34]). Interestingly, although E6AP assembles K48-linked chains, the NEDD4 family specifically assembles K63 linkages in vitro. Elegant biochemical and structural work has identified many features important for linkage specificity ([@bib17; @bib18; @bib20; @bib29]). Because of their ability to dictate linkage specificity and many hints in the literature ([@bib42; @bib55]), we characterized human HECT E3 ligases to investigate their ability to assemble atypical chains.

One way to assess which linkage types are assembled is to utilize a panel of Ub mutants in which each Lys is mutated to Arg either inclusively (K0) or with the exception of one position (Kx-only) ([Figure S1](#app3){ref-type="sec"}A). This analysis reproduced K63 specificity of NEDD4L (amino acids \[aa\] 576--955) ([Figure S1](#app3){ref-type="sec"}B) and indicated a broader specificity of the unstudied HECT E3 ligase AREL1 (aa 436--823, [Figure 1](#fig1){ref-type="fig"}A; [Figure S1](#app3){ref-type="sec"}C), which seemed to assemble K33 linkages efficiently.

Using Ub mutants for chain assembly has multiple caveats. To understand which linkage types are assembled in E3 ligase reactions with wild-type (WT) Ub, we used absolute quantification (AQUA)-based mass spectrometry ([@bib23]). For this, tryptic digests of chain assembly reactions are spiked with isotope-labeled GlyGly-modified standard peptides derived from each potential linkage site, allowing absolute quantification of all chain types ([@bib23]). NEDD4L assembled K63 chains almost exclusively (96%) ([Figure S1](#app3){ref-type="sec"}D), whereas UBE3C assembled K48 (63%), K29 (23%), and K11 linkages (10%) ([Figure 1](#fig1){ref-type="fig"}B), as reported previously ([@bib29; @bib55]). Interestingly, AREL1 assembled 36% of K33, 36% of K11, 20% of K48, and small amounts of K63 and K6 linkages ([Figure 1](#fig1){ref-type="fig"}C). The high abundance of K11 linkages in AREL1 reactions contrasts with the finding from K11-only Ub that was incorporated poorly into chains ([Figure S1](#app3){ref-type="sec"}C), suggesting that mutated Lys residues are crucial for assembly of this linkage type by AREL1. Abrogating K11 linkage production by AREL1 using Ub K11R led to 71% of K33 and 24% of K48 linkages ([Figure S1](#app3){ref-type="sec"}E). The fact that K48 linkages stayed relatively constant indicated that this chain type is assembled as a constant byproduct of AREL1.

A recent characterization of AREL1 function ([@bib22]) has suggested that the pro-apoptotic proteins SMAC, HtrA2, and ARTS are among its substrates and further indicated that they interact via the AREL1 HECT domain (rather than an auxiliary N-terminal domain). We expressed fragments of SMAC and HtrA2 ([Figure 1](#fig1){ref-type="fig"}D) and used these proteins as in vitro AREL1 substrates. AREL1 ubiquitinated all proteins efficiently ([Figures 1](#fig1){ref-type="fig"}E and 1F). Strikingly, AQUA analysis of modified substrates showed that AREL1 had assembled \>80% of K33 linkages in the polyUb chains on all three substrates ([Figure 1](#fig1){ref-type="fig"}G).

Generating K29- and K33-Linked PolyUb {#sec2.2}
-------------------------------------

AREL1 and UBE3C also assembled free Ub chains. Precipitation of enzymes by perchloric acid in an assembly reaction enriched free polyUb chains of varying lengths (see gel in [Figure 2](#fig2){ref-type="fig"}A). AREL1 assembled WT Ub into di- and triUb with (for triUb) 75% of K33-linkages and only 13% of K11-linked and 7% of K63-linked chains ([Figure 2](#fig2){ref-type="fig"}A). Using K11R Ub, we generated up to 86% of K33 linkages in triUb ([Figure 2](#fig2){ref-type="fig"}A). To generate pure K29 and K33 chains from WT Ub, we acid-precipitated the reaction and treated the free chains with a panel of linkage-specific DUBs consisting of K11-specific Cezanne ([@bib31]) as well as enhanced versions of K48-specific OTUB1^∗^ (an UBE2D2-OTUB1 fusion) and K63-specific AMSH^∗^ (a STAM2-AMSH fusion) ([Figure 2](#fig2){ref-type="fig"}B; [Figures S2](#app3){ref-type="sec"}A and S2B; [Supplemental Experimental Procedures](#app3){ref-type="sec"}). The resulting K29- and K33-linked polyUb chains were purified by cation exchange and were 87% and 93% pure, respectively; uncleavable by Cezanne, OTUB1^∗^, or AMSH^∗^; but hydrolyzed efficiently by the K29/K33-specific DUB TRABID ([@bib28]) ([Figures 2](#fig2){ref-type="fig"}C--2E; [Figures S2](#app3){ref-type="sec"}C and S2D; also see below).

K29- and K33-Linked diUbs Adopt Open Conformations in Solution {#sec2.3}
--------------------------------------------------------------

With new linkage types at hand, we set out to understand their structural features. We crystallized K33-linked di- and triUbs ([Figure S3](#app3){ref-type="sec"}). The K33-linked diUb crystallized in space group *I*4, not observed previously for Ub, and a structure to 1.85 Å resolution revealed eight molecules forming four identical Ub dimers with clear electron density for the K33 linkages ([Figures S3](#app3){ref-type="sec"}A and S3B; [Table 1](#tbl1){ref-type="table"}). In this structure, K33-linked diUb is compact, and distal and proximal Ub moieties interact symmetrically via their Ile36 hydrophobic patches ([Figure S3](#app3){ref-type="sec"}A). The symmetric interface did not provide a model for the conformation of a longer K33 chain.

A second crystal structure for K33-linked triUb was obtained at 1.68 Å in space group *P*2~1~2~1~2~1~ with similar unit cell dimensions as the Ub reference structure (1ubq; [@bib47]), and also contains only one Ub molecule per asymmetric unit ([Table 1](#tbl1){ref-type="table"}). Examination of adjacent asymmetric units only allowed one possibility for K33 chain formation ([Figure S3](#app3){ref-type="sec"}C), although the C termini and isopeptide linkages were poorly ordered and not built in the model ([Figure S3](#app3){ref-type="sec"}D). The Ub moieties in K33 chains were related by translational symmetry and, in contrast to the compact diUb structure, adopted an open conformation in which Ub moieties do not interact with each other except by two polar side chain contacts ([Figure S3](#app3){ref-type="sec"}C). The distinct conformations of di- and triUb could be due to differences in crystallization conditions but highlight the underlying problem that crystallization may present an incomplete picture of the dynamic states of free polyUb in solution.

We therefore turned to nuclear magnetic resonance (NMR), which is better suited to analyze dynamic Ub chains. When Ub polymers adopt open conformations in solution, the spectra resemble free monoUb, showing a small number of perturbations surrounding the isopeptide linkage. The best example for this is K63-linked Ub ([@bib46]) which does not form a defined interface in solution ([@bib54]). Contrasting this are compact conformations in which defined interfaces are formed. In K48-linked diUb ([@bib45]), resonances of proximal and distal Ub moieties adopt distinctly different chemical shift positions (splitting) because of their different chemical environment.

We assembled K33-linked diUb from ^13^C, ^15^N-labeled monoUb and measured 2D band-selective excitation short transient transverse relaxation-optimized spectroscopy (BEST-TROSY) spectra, revealing well dispersed peaks similar to monoUb ([Figure 3](#fig3){ref-type="fig"}A). Assignment of the spectra revealed splitting of 16 resonances. The small chemical shift perturbations (CSPs) in all split resonances could be attributed to the proximal Ub, whereas the distal Ub was unperturbed ([Figure 3](#fig3){ref-type="fig"}B). Mapping of the perturbed residues on Ub revealed a small region surrounding the isopeptide bond at K33 ([Figure 3](#fig3){ref-type="fig"}C). Almost identical spectra were obtained for ^15^N-labeled, K29-linked diUb, in which 19 resonances were split and mildly perturbed ([Figure 3](#fig3){ref-type="fig"}D). Both diUb spectra resembled the K63 diUb spectrum ([@bib46]; [Figure 3](#fig3){ref-type="fig"}E). Together, this indicates that both K29- and K33-linked diUb do not form defined interfaces in solution but, rather, exist in open conformations.

TRABID K29/K33 DUB Specificity Is Retained with Longer Chains {#sec2.4}
-------------------------------------------------------------

TRABID, a DUB from the OTU family, is the only known protein to date that acts specifically on K29- and K33-linked Ub chains ([@bib28; @bib31]; [Figure 4](#fig4){ref-type="fig"}A). In TRABID, a C-terminal OTU domain of the A20 subfamily is preceded by an ankyrin repeat Ub binding domain (AnkUBD) that enables a non-specific OTU domain to preferentially cleave K29- and K33-linked diUb ([@bib28]). This construct hydrolyzes K63-linked chains with 40-fold lower activity compared to K29 chains ([@bib48]). Because of the necessity for chemical synthesis of K27, K29, and K33 linkages, these experiments were so far confined to diUb cleavage. We now confirm that the specificity of TRABID AnkOTU also holds true for longer tetraUb chains. TRABID cleaved K33-linked tetraUb with a significantly higher activity compared with K63-linked chains ([Figures 2](#fig2){ref-type="fig"}C, 2D, and [4](#fig4){ref-type="fig"}B; [Figure S4](#app3){ref-type="sec"}A).

TRABID NZF1 Specifically Binds K29- and K33-Linked Chains {#sec2.5}
---------------------------------------------------------

In addition to the C-terminal AnkOTU catalytic domain, TRABID contains three N-terminal NZF domains ([Figure 4](#fig4){ref-type="fig"}A) that bind polyUb and are important, together with the AnkUBD, for TRABID localization to characteristic punctate structures in cells ([@bib28]). Surprisingly, analyzing the preference of the N-terminal NZF domains in pull-down experiments revealed the specificity of the 3xNZF module (aa 1--263 or 1--178) for K29- and K33-linked diUb, whereas K63-diUb binding was barely detectable ([Figure 4](#fig4){ref-type="fig"}C; [Figure S4](#app3){ref-type="sec"}B). This resembled the cleavage specificity of the AnkOTU catalytic domain ([Figure 4](#fig4){ref-type="fig"}B; [@bib28]). Pull-down experiments with individual NZF domains showed that K29/K33 specificity could be attributed entirely to the N-terminal NZF1 domain (aa 1--33), which bound these chains as well as the 3xNZF modules but did not interact with K63-linked diUb.

To measure affinities, we established a surface plasmon resonance (SPR)-based binding assay in which monoUb and all types of diUb were immobilized, and NZF1 binding was detected by SPR ([Figure 4](#fig4){ref-type="fig"}D). Of the nine datasets, seven were fitted to a one-site binding model with NZF1 affinities between 190--370 μM ([Figures S4](#app3){ref-type="sec"}C and S4D). For K29- and K33-linked diUb, fitting to a one-site model resulted in high residuals, and data were fitted to a two-site binding model, revealing significantly higher affinities (K~d~^high^ 3.6 and 4.9 μM, respectively, and 180/200 μM affinities for K~d~^low^) ([Figure S4](#app3){ref-type="sec"}C). The high binding affinities of K29- and K33-linked diUb were consistent with the pull-down experiments ([Figure 4](#fig4){ref-type="fig"}C).

Curiously, NZF2 and NZF3 did not bind diUb in pull-down assays. To understand whether these domains can bind Ub, binding studies were performed by NMR using ^15^N-labeled Ub. NZF1 interacts with monoUb, leading to chemical shift perturbation maps that show the characteristic profile for interactions via the Ub Ile44 patch ([Figure 4](#fig4){ref-type="fig"}E; [Figure S4](#app3){ref-type="sec"}E). This is consistent with the known binding mode of NZF domains first derived for Npl4 ([@bib2]), and mapping of perturbed residues on Ub suggests similar interactions ([Figure S4](#app3){ref-type="sec"}E). Titrations of NZF2 and NZF3 resulted in similar CSP profiles ([Figure 4](#fig4){ref-type="fig"}F; [Figure S4](#app3){ref-type="sec"}E). Using NMR titration experiments, we derived binding constants for the monoUb-NZF interactions, with K~d~ values of ∼440 μM for NZF1, ∼1 mM for NZF2, and ∼540 μM for NZF3 ([Figures S4](#app3){ref-type="sec"}F and S4G), which is in a typical range for monoUb binding to small UBDs. Although this showed that all NZF domains are functional in Ub binding, it did not explain why only NZF1 showed K29/K33 specificity.

Structure of a K33-Linked Ub Polymer Bound to TRABID NZF1 {#sec2.6}
---------------------------------------------------------

To understand the underlying molecular basis for the K29/K33 specificity of TRABID NZF1, we crystallized the complex with K33-diUb and determined a structure to 3.4 Å resolution. High solvent content (67%, Matthews coefficient ∼ 3.8) led to high-contrast maps ([Figure S5](#app3){ref-type="sec"}A) and allowed building of a complete model with good statistics ([Table 1](#tbl1){ref-type="table"}). It was immediately apparent that the arrangement of Ub molecules in the crystal lattice generated seemingly infinite helical polymers ([Figures 5](#fig5){ref-type="fig"}A and 5B; [Figure S5](#app3){ref-type="sec"}B). The K33-filament forms a helix with 5-fold symmetry. The helix turns twice between the first and sixth molecule ([Figure 5](#fig5){ref-type="fig"}A). The asymmetric unit contains five Ub molecules and five NZF domains ([Figures 5](#fig5){ref-type="fig"}A and 5B). The electron density for K33 linkages can be discerned for one isopeptide bond ([Figure S5](#app3){ref-type="sec"}C). The electron density for the isopeptide bonds is weak because of flexibility but also because diUb was crystallized, and each linkage in the asymmetric unit is only at half occupancy. K29 is in close proximity to the tail of the distal Ub, and it is conceivable that K29-linked polymers interact with TRABID NZF1 in a similar manner and can form similar filaments. This was supported by NMR experiments where NZF1 was added to either ^15^N-labeled K33- or K29-linked diUb. NZF1 binding leads to chemical shift perturbations along the same face of the proximal Ub moieties, indicating that the overall orientation of the proximal Ub is similar ([Figure S5](#app3){ref-type="sec"}D).

Interactions between Ub molecules are identical along the filament and involve exclusively polar contacts ([Figure 5](#fig5){ref-type="fig"}C). A distal Ub interacts with the Ub helix of a proximal Ub, forming hydrogen bonds between Gln49 (distal Ub) and Gln31 (proximal Ub) and charged interactions between Arg42 and Arg72 (distal Ub) and Asp32 (proximal Ub) ([Figure 5](#fig5){ref-type="fig"}C). This exposes the hydrophobic Ile44 and Ile36 patches of each Ub molecule and enables binding of one NZF domain to each Ile44 patch along the filament ([Figure 5](#fig5){ref-type="fig"}A).

Explaining the Specificity of TRABID NZF1 for K33 Linkages {#sec2.7}
----------------------------------------------------------

Consistent with other linkage-specific NZF domains, NZF1 of TRABID forms a bidentate interaction across the distal and proximal Ub moieties ([Figures 5](#fig5){ref-type="fig"}B and [6](#fig6){ref-type="fig"}A). This has been seen previously for the TAB2 and HOIL-1L NZF domains, which interact specifically with K63- and M1-linked diUb, respectively ([Figure 6](#fig6){ref-type="fig"}B; [Figure S6](#app3){ref-type="sec"}A; [@bib27; @bib35; @bib36]), and can be superimposed with TRABID NZF1 with low root-mean-square deviations (RMSDs) (0.5--0.6 Å). TRABID NZF1 binds the distal Ub at the Ile44 patch via the canonical NZF interaction involving Thr14, Tyr15, and Met26 ([Figure 6](#fig6){ref-type="fig"}A). This binding mode through the T-Y/F-Φ motif is conserved in all NZF interactions described to date ([Figure S6](#app3){ref-type="sec"}B; [@bib2]) and is consistent with the NMR interaction data in [Figures 4](#fig4){ref-type="fig"}E and 4F (see above). The proximal Ub is bound by TRABID NZF1 in an unusual way, at a binding site involving the start of the Ub α helix and two nearby loop regions ([Figure 6](#fig6){ref-type="fig"}A). In this interaction, Ub Glu24 makes key interactions with a complementary pocket on NZF1 formed by Tyr15, Asn17, Trp18, and Thr25. The Ub Glu24 side chain can form hydrogen bonds with side chains of these four residues ([Figure 6](#fig6){ref-type="fig"}A). In addition, the solvent-exposed TRABID NZF1 Trp18 side chain forms apolar contacts with the Asp52-Gly53 loop of the proximal Ub, and NZF1 Ser20 forms a hydrogen bond with the Gly53 carbonyl group ([Figure 6](#fig6){ref-type="fig"}A). All interacting residues in NZF1 are conserved in evolution ([Figure 6](#fig6){ref-type="fig"}C).

A comparison of the TAB2 and HOIL-1L diUb complexes reveals how NZF domains have achieved their specificity. Although the canonical interaction with a distal Ub is conserved, the proximal Ub is rotated in each complex to form distinct interactions with a second patch on the NZF domain. In the case of TAB2, the second interaction with a proximal Ub is also via the Ile44 patch ([@bib27; @bib35]; [Figure 6](#fig6){ref-type="fig"}B). In HOIL-1L, a short helical NZF extension contributes the secondary contacts, which are mediated by the Phe4 patch of the proximal Ub ([@bib36]; [Figure S6](#app3){ref-type="sec"}A). Superposition of structures reveals why TAB2 is unable to bind the K33 filament: Glu685 would clash directly with Glu24 of the proximal Ub ([Figure S6](#app3){ref-type="sec"}C). Similarly, TRABID NZF1 Trp18 clashes with the proximal Ub when the TAB2-K63 diUb complex is superimposed ([Figure S6](#app3){ref-type="sec"}D) (although mutation of this residue did not enable high-affinity K63 diUb binding; see below). Finally, the structure also reveals why TRABID NZF2 and NZF3 are unable to bind K33 polymers: Ser20 in NZF1 is replaced by Lys or Arg residues in NZF2/3 ([Figure S6](#app3){ref-type="sec"}E), which affects binding ([Figure 6](#fig6){ref-type="fig"}E; see below). However, mutation of Lys165 in NZF3 to Ser did not enhance binding to K29/K33 chains (data not shown), suggesting that the remaining differences play a role as well. It is fascinating that, given their small size, NZF domains have evolved so many distinct binding modes to recognize different linkage types.

Validation of the TRABID-K33 Chain Interaction {#sec2.8}
----------------------------------------------

To validate the interaction between TRABID NZF1 and K33-diUb biochemically, we mutated residues in the interfaces. We assembled K33-linked diUb from a Ub K11R/E24R mutant that would abrogate its interactions with the proximal interface of TRABID NZF1. Indeed, TRABID NZF1 is unable to pull down K11R/E24R diUb ([Figure 6](#fig6){ref-type="fig"}D), confirming that this Ub residue, which has not been implicated in any other Ub interaction known to us, is important for TRABID NZF1 binding.

Next, NZF1 was mutated ([Figures 6](#fig6){ref-type="fig"}E--6G; [Figure S6](#app3){ref-type="sec"}F). NZF1 W18A and T25D were unable to interact with K33-linked diUb in pull-down experiments, and Y15F and S20R significantly weakened binding compared with wild-type NZF1 ([Figure 6](#fig6){ref-type="fig"}E). SPR measurements for these mutants interacting with K29- or K33-linked diUb revealed that, although Y15F had to be fitted to a two-site binding model with a lower K~d~^high^ (11 μM), W18A and T25D fit well with a one-site binding model, indicating that they interacted only via the Ub Ile44 patch ([Figures 6](#fig6){ref-type="fig"}F and 6G; [Figure S6](#app3){ref-type="sec"}F; [Supplemental Experimental Procedures](#app3){ref-type="sec"}). No binding could be detected when mutating the canonical Thr14/Tyr15 (to Leu/Val, termed TY14LV), consistent with disruption of the Ile44 patch interaction.

This shows the importance of these residues for NZF1 Ub interactions, validates the observed binding mode in the structure for K33-diUb, and further confirms a similar binding mode for K29-linked chains ([Figures 5](#fig5){ref-type="fig"} and [6](#fig6){ref-type="fig"}). Moreover, this emphasizes that conserved residues on previously unknown proximal binding sites in NZF domains (and perhaps other small UBDs) can furnish UBDs with chain preference.

Localization of Inactive TRABID to Ub-Rich Puncta Relies on NZF1 Binding to Atypical Ub Chains {#sec2.9}
----------------------------------------------------------------------------------------------

Catalytically inactive TRABID C443S (ciTRABID) localizes to Ub-rich punctate structures in cells, and this depends on its Ub-binding capability ([@bib28; @bib41]). TRABID contains at least six independent Ub binding interfaces: at least four in the 3xNZF module, one in the AnkUBD, and at least one in the catalytic domain. Because our biochemical analysis indicated that NZF1 provides TRABID with high-affinity binding for K29/K33 chains, we assessed how important individual NZF domains are for ciTRABID localization to puncta ([Figure 7](#fig7){ref-type="fig"}).

Mutation of the canonical Ub binding site in NZF1 (NZF1^∗^; [Figure 7](#fig7){ref-type="fig"}A) led to a diffuse (mostly nuclear) ciTRABID localization without puncta ([Figure 7](#fig7){ref-type="fig"}B). In contrast, the same mutation in NZF2 or NZF3 (NZF2^∗^ and NZF3^∗^, respectively) showed identical punctate pattern as ciTRABID, with a similar number of dots ([Figures 7](#fig7){ref-type="fig"}B and 7C; [Figure S7](#app3){ref-type="sec"}A). This shows that Ub binding by NZF1 is crucial for forming punctate structures in the ciTRABID background. We also tested whether the identified mutants in the proximal Ub binding site of NZF1 are defective in punctum formation. ciTRABID W18A and ciTRABID T25D showed a reduction in the number of puncta per cell ([Figures 7](#fig7){ref-type="fig"}B and 7C; [Figure S7](#app3){ref-type="sec"}A). This is consistent with the distal Ub binding site still being intact and maintaining residual low-affinity Ub binding capability. However, the significant reduction of dots with ciTRABID W18A suggests that the NZF1:K29/K33 interface promotes punctum formation ([Figure 7](#fig7){ref-type="fig"}D).

Discussion {#sec3}
==========

Chain linkage profiling by AQUA mass spectrometry is a powerful strategy to discover the missing ligases for atypical chains and to provide mechanistic insights into Ub chain assembly. Because of their mechanism of E2-independent linkage determination, HECT E3 ligases are good candidates to assemble atypical chains, and, although several have been suggested to assemble atypical linkages, only a subset have been characterized biochemically ([@bib42; @bib55]). We show here that AREL1 predominantly assembles K33 linkages in free chains and on substrate proteins. Together with UBE3C, which has been reported to generate K48 and K29 linkages ([@bib55]), we provide a protocol to generate pure K29- and K33-linked polyUb enzymatically for in vitro analysis.

Our protocol to generate WT K29- or K33-linked polyUb relies on the recently discovered linkage specificity in DUBs, and we used these enzymes preparatively to remove unwanted linkage types in chains. Our redesigned forms of K48-specific OTUB1 and K63-specific AMSH are highly active and have proven to be useful for this purpose. Together with Ub chain restriction (UbiCRest) analysis ([@bib31]), this highlights the utility of linkage-specific DUBs in studying the Ub system.

K29- and K33-linked chains are flexible and able to adopt multiple conformations, much like the remaining chain types ([@bib54]). Although the diUb crystal structure has captured a compact conformation of K33-linked diUb, solution studies suggest open conformations for both chain types without formation of defined interfaces, as reported for chemically assembled K33-linked chains ([@bib9]).

Ub binding proteins can stabilize chain conformations ([@bib54]), and it is therefore important to understand how polyUb is recognized by UBDs in a linkage-specific fashion. Our discovery of K29/K33 specificity in the N-terminal TRABID NZF1 domain enabled further insights into linkage-specific UBDs. NZF domains are small zinc-binding folds with remarkable linkage specificity that is achieved by bidentate interactions, whereby the ∼30-aa NZF fold intercalates between and interacts with two Ub molecules. The TRABID NZF1 contacts the canonical Ile44 hydrophobic patch on the distal Ub and an unusual surface on the proximal Ub surrounding Glu24 of the Ub helix. The observed binding mode is validated by mutational analysis, which indicates that it may be shared between K29- and K33-linked chains, explaining TRABID NZF1 cross-specificity. The structure also explains why TAB2 or TRABID NZF2 and NZF3 are unable to bind K29/K33-linked chains in a similar manner.

A remarkable feature of the structure is the assembly of the K33 diUb with NZF1 into filaments that make up the entire crystal. In these filaments, each Ub-Ub contact is identical, each NZF domain binds two Ub molecules, and each Ub binds two NZF domains. The helical Ub filament bound to NZF1 domains provides an immediate model for interactions with the TRABID 3xNZF module, which, despite the lack of K29/K33 specificity in NZF2 and NZF3, could assemble on a Ub filament ([Figure S7](#app3){ref-type="sec"}B). This is enabled by flexible linkers that vary in sequence and length but have a minimal length of 35 aa (NZF1-NZF2) and 28 aa (NZF2-NZF3) throughout evolution ([Figure S7](#app3){ref-type="sec"}C). Such linkers would easily be able to bridge the space between adjacent NZF domains when binding a K29/K33 filament ([Figure S7](#app3){ref-type="sec"}B).

Further studies by complementary techniques will be required to see whether K29- and K33-linked chains indeed form filaments in the presence of NZF1 in vivo. We have previously described the accumulation of catalytically inactive TRABID into characteristic Ub-containing puncta in cells, which depends on functional NZF domains ([@bib28]). Here we extend these studies to show that, indeed, NZF1 and its K29/K33-specific binding mode are important for punctum formation. The cellular structures covered with K29/K33 chains that lead to punctum formation are intriguing and require further investigation.

Nonetheless, some new roles of K33-linked chains are emerging. AREL1 has been reported to ubiquitinate cytosolic inhibitor of apoptosis (IAP) antagonists, including SMAC, HtrA2, and ARTS, which leads to their proteasomal degradation ([@bib22]). We show here that AREL1 polyubiquitinates SMAC and HtrA2 with \>80% of K33 linkages in vitro. It will be interesting to see whether K33-linked chains can be linked to antiapoptotic signaling.

In cells, K33 chains have been found on AMPK kinases (together with K29-linked chains; [@bib1]), on T cell receptor (TCR) ζ ([@bib14]), and on Coronin-7 ([@bib56]). The latter study used an elegant Ub replacement strategy where cells express Ub K33R instead of WT Ub and revealed roles of this chain type in post-Golgi transport ([@bib56]). Interestingly, these reports and our previous work on TRABID ([@bib28]) agreed that K33-linked chains are likely non-degradative, which is consistent with this chain type not being significantly enriched upon proteasomal inhibition ([@bib21]). The ability of K33 chains to act as a proteasomal degradation signal requires further study.

Such in vivo studies of atypical chain types can now be supplemented with powerful biochemical tools reported here. The TRABID NZF1 domain could serve as an excellent tool in future studies, e.g., when used as a Ub chain sensor ([@bib40; @bib44]) or as a K29/K33-specific affinity reagent ([@bib12]). The availability of K29- and K33-linked polymers and new affinity reagents will enable a better understanding of these uncharacterized Ub signals.

Experimental Procedures {#sec4}
=======================

Please see the [Supplemental Experimental Procedures](#app3){ref-type="sec"} for more detailed information.

Protein Production {#sec4.1}
------------------

The His6-SUMO-AREL1 (436--823) and His6-SUMO-UBE3C (693--1083) constructs (both from the pOPIN-S vector) and the His6-GST-TRABID NZF construct (from the pOPIN-K vector) were expressed in Rosetta2 (DE3) pLacI cells and purified by affinity chromatography. Tags were removed by incubation with SENP1 or 3C protease. Further purification was performed by anion exchange and/or size exclusion chromatography.

Ub Chain Composition Mass Spectrometry Analysis {#sec4.2}
-----------------------------------------------

Ub chains were separated on a NuPAGE 4%--12% gradient gel (Invitrogen) before in-gel digestion with trypsin and the addition of Ub AQUA peptide internal standards according to [@bib23]. 10 μl of each sample was directly injected onto an EASY-Spray reverse-phase column (C18, 3 μm, 100 Å, 75 μm × 15 cm) using a Dionex UltiMate 3000 high-pressure liquid chromatography system (Thermo Fisher Scientific) and analyzed on a Q-Exactive mass spectrometer (Thermo Fisher Scientific) using parallel reaction monitoring (PRM), similar to [@bib43]. Data were analyzed further according to [@bib23].

K29 Chain Generation {#sec4.3}
--------------------

K29-linked polyUb was assembled from 3 mM Ub, 1 μM E1, 10 μM UBE2L3, and 32 μM His6-SUMO UBE3C (aa 693--1083) in buffer containing 10 mM ATP, 10 mM MgCl~2~, 40 mM Tris (pH 8.5), 100 mM NaCl, 0.6 mM DTT, and 10% (v/v) glycerol overnight at 37°C. After precipitation of enzymes by perchloric acid (0.25% \[v/v\]), unanchored chains were buffer-exchanged into 50 mM Tris (pH 7.4), 150 mM NaCl, and 4 mM DTT and treated with OTUB1^∗^ (1 μM), AMSH^∗^ (1 μM), and Cezanne (400 nM) for 60 min at 37°C. A second round of acid precipitation and cation exchange chromatography was used for purification.

K33 Chain Generation {#sec4.4}
--------------------

K33-linked polyUb was assembled like K29-linked chains from a reaction that contained 36 μM AREL1 (aa 436--823) instead of UBE3C. The addition of 10% (v/v) glycerol in the reaction buffer prevented AREL1 precipitation during the reaction.

Pull-Down Assays {#sec4.5}
----------------

Pull-down assays were performed as described previously ([@bib27]). Proteins were visualized by silver staining using the Silver Stain Plus kit (BioRad) according to manufacturer's protocols or by western blotting using a rabbit anti-Ub antibody (Millipore).

Nuclear Magnetic Resonance Studies {#sec4.6}
----------------------------------

NMR experiments were performed in NMR PBS (18 mM Na~2~HPO~4~, 7 mM NaH~2~PO~4~ (pH 7.2), and 150 mM NaCl) with 5% D~2~O added as a lock solvent. NMR acquisition was carried out at 298 K on a Bruker Avance III 600 MHz spectrometer equipped with a cryogenic triple resonance TCI probe. Topspin (Bruker) and Sparky (Goddard & Kneller, University of California San Francisco; <http://www.cgl.ucsf.edu/home/sparky/>) software packages were used for data processing and analysis, respectively. ^1^H,^15^N 2D BEST-TROSY experiments ([@bib10]) allowed the calculation of weighted chemical shift perturbation using the equation √(Δ^1^H)^2^+((Δ^15^N)^2^/5). K~d~ values for NZF-Ub interactions were determined according to [@bib51].

Crystallization, Data Collection, and Refinement {#sec4.7}
------------------------------------------------

Crystals of K33-linked diUb, triUb, and of the TRABID NZF1-K33 diUb complex were grown by sitting drop vapor diffusion. Diffraction data were collected at Diamond Light Source beamlines I03 and I24, and the structures were solved by molecular replacement and refined to the final statistics in [Table 1](#tbl1){ref-type="table"}.
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![Role of HECT E3 Ligases in Assembling Atypical Ub Chains\
(A) Domain structures of UBE3C and AREL1 (KIAA0317) (top) and constructs used in this study (bottom).\
(B) Schematic of an assembly reaction with UBE3C, UBE2L3 (UbcH7), E1, and WT Ub (left). The linkage composition in the reaction mixture was analyzed by AQUA-based MS/MS (right).\
(C) Reaction as in (B) with AREL1, UBE2L3, E1, and WT Ub.\
(D) Domain structures of the pro-apoptotic proteins SMAC and HtrA2 (top) and the expressed constructs used in this work (bottom).\
(E) AREL1 is able to assemble chains onto SMAC and HtrA2 in an in vitro ubiquitination reaction that depends on ATP. Ubiquitinated, His6-tagged substrates are enriched following Ni^2+^ affinity binding. SM, SMAC (56--239); H359, HtrA2 (359--458); H134, HtrA2 (134--458); §, AREL1; ^∗^, UBE2L3.\
(F) Western blot against Ub of the Ni^2+^-enriched reaction from (E).\
(G) AQUA MS/MS profiles of the ubiquitinated substrates purified from (E).](gr1){#fig1}

![Purification of Unanchored K29/K33 PolyUb Chains\
(A) Schematic of the assembly of K33-linked Ub chains using either WT or K11R Ub (top). AQUA profiles of triUb using either WT (top right) or K11R Ub (bottom right; K6 linkage was excluded from the quantitative analysis because of the K11R substitution). Bottom: corresponding SDS-PAGE gel for assembly of free chains. −ATP, initial reaction without ATP addition; O/N, overnight incubation of the assembly reaction; +PA, perchloric acid treatment of the assembly reaction.\
(B) Schematic representation of the purification of K33-linked polyUb chains. Following the assembly reaction, perchloric acid treatment removes the ubiquitinated and unmodified forms of E1, E2, and E3. Linkage-selective DUBs are then used to remove undesired Ub linkages. An additional perchloric acid step is required to inactivate the DUBs prior to cation exchange chromatography (bottom), which resolves the homotypic chains based on linkage length. Bottom center: SDS-PAGE of purified K33-linked di-, tri-, and tetraUb. Bottom right: AQUA MS/MS of purified K33-linked diUb.\
(C) Deubiquitinase assay of purified K33-linked di- and triUb. --, no DUB; C, 200 nM Cezanne (K11-specific); T, 350 nM TRABID (K29/K33-specific); B1, 1 μM OTUB1^∗^ (K48-specific); A, 1 μM AMSH^∗^ (K63-specific).\
(D) K29-linked polyUb chains can be purified analogous to the schematic shown in (B). Purified K29-linked di- and triUb were treated with DUBs as in (C).\
(E) AQUA mass spectrometry profile of purified K29 diUb.](gr2){#fig2}

![NMR Analysis of K29/K33 Chains\
(A) BEST-TROSY spectra for ^15^N-K33 diUb (orange) and ^15^N-monoUb (black). Complete assignment of resonances from the proximal (p) or distal (d) moieties from a ^13^C, ^15^N-K33 diUb sample are shown.\
(B) Chemical shift perturbation of distal (orange) and proximal (beige) resonances with respect to monoUb. Grey bars, exchange-broadened resonances; asterisks, proline residues.\
(C) Resonances that display a perturbation of more than 1 σ are mapped onto the surface of monoUb (purple) and cluster around the K33 residue (orange). No significant perturbations were observed on the distal Ub moiety, consistent with an open conformation of K33 diUb.\
(D) BEST-TROSY spectra for ^15^N K29 diUb (purple) and monoUb (black).\
(E) BEST-TROSY spectra for ^15^N K63 diUb (cyan) and monoUb (black).](gr3){#fig3}

![Characterization of TRABID Specificity\
(A) Domain structure of human TRABID. The AnkOTU fragment has been characterized in detail in [@bib28]. Boundaries of the NZF domain fragments analyzed here are shown.\
(B) Deubiquitination assay of TRABID AnkOTU against K6-, K33-, and K63-linked tetraUb. See [Figure S4](#app3){ref-type="sec"}A for a reaction at a lower DUB concentration.\
(C) Pull-down analysis of NZF fragments with a panel of diUb covering all linkage types. Left: the input chains and GST-NZF constructs used. Right: pull-down analysis shown by silver stain and anti-Ub western blot. See [Figure S4](#app3){ref-type="sec"}B for additional controls.\
(D) SPR binding experiment of NZF1 to monoUb and the eight different diUb species with error bars representing SEs. K~d~ values derived from two experiments are shown. See [Figure S4](#app3){ref-type="sec"}C for best-fit parameters and values of SEs.\
(E) NMR analysis of isolated NZF1 binding to ^15^N-labeled monoUb. The chemical shift perturbation for Ub from binding to 600 μM of NZF1 is shown. Grey bars, exchange-broadened residues; asterisks, proline residues. See [Figures S4](#app3){ref-type="sec"}E--S4G for titration data.\
(F) NMR analyses as in (E) but for NZF2 and NZF3.](gr4){#fig4}

![Structure of K33 Filaments Bound to NZF1\
(A) Structure of the K33-linked Ub filament as observed in the crystal, showing three adjacent asymmetric units (black outline). Ub molecules are shown as a surface representation with a gradient from orange (distal) to beige (proximal), and Ile44 patches are indicated in blue. NZF1 is shown as a red ribbon with gray Zn^2+^ atoms. A schematic is shown below. Right: view of the filament down the 5-fold symmetry axis. ASU, asymmetric unit.\
(B) Content of the asymmetric unit, colored as in (A). K33 isopeptide linkages are shown as stick representations; see [Figure S5](#app3){ref-type="sec"}C for electron density.\
(C) Close-up view of one Ub in the filament, showing interacting residues as a stick representation. Hydrogen bonds are shown as black dashed lines. The K33 and K29 side chains are also shown.](gr5){#fig5}

![Explaining the K29/K33 Specificity of TRABID NZF1\
(A) Detailed view of the interactions between TRABID NZF1 (red) and K33-linked diUb (orange/beige). Interacting residues are labeled, and hydrogen bonds are shown as black dashed lines.\
(B) As in (A) for the TAB2 NZF interaction with K63-linked diUb (cyan).\
(C) Sequence alignment of TRABID NZF1 from a diverse range of species and human TAB2 NZF domains. Interacting residues are indicated with orange (distal Ub) and beige (proximal Ub) dots. Thr25 in TRABID NZF1 is replaced with Glu685 in TAB2 NZF, which would prevent K29/K33 binding in TAB2 NZF.\
(D) Left: Ub chains were assembled into K33 diUb with AREL1 using K11R or K11R/E24R Ub. Right: pull-down assays with TRABID NZF1 and diUb variants.\
(E) Pull-down assays as in [Figure 4](#fig4){ref-type="fig"}C for TRABID NZF1 mutants.\
(F and G) SPR binding experiment of NZF1 and its mutants against K29 diUb (F) and K33 diUb (G) with the respective K~d~ values indicated. SEs from two experiments are shown as error bars. See [Figure S6](#app3){ref-type="sec"}F for values of SEs and best-fit parameters.](gr6){#fig6}

![Localization of Catalytically Inactive TRABID Mutants in Cells\
(A) Constructs used in localization experiments for GFP-TRABID fusions. Yellow stars indicate single amino acid substitutions, whereas black crosses denote two amino acid substitutions that abrogate Ub binding in the respective domain.\
(B) Localization of catalytically inactive full-length GFP-TRABID (ciTRABID) constructs. GFP-ciTRABID localizes to distinct puncta in COS-7 cells. Mutations in this background that abrogate Ub binding of NZF1 (NZF1^∗^) lead to a significant decrease in the number of dots, whereas the equivalent mutations in NZF2 (NZF2^∗^) or NZF3 (NZF3^∗^) do not lead to a change in the number of puncta. Cartoon representations of the constructs are shown as in (A). Scale bars, 10 μm.\
(C) The same experiment with single amino acid substitutions in the proximal Ub binding site of NZF1.\
(D) Statistical analysis of experiments in (B) and (C) with an average number of puncta per cell for the different mutants and corresponding SEs. p Values are given in reference to the ciTRABID mutant, and significant values (α \< 0.05) are shown in boldface. Error bars represent SEs.](gr7){#fig7}

###### 

Data Collection Statistics

                                                        K33 diUb                                                    K33 triUb                  TRABID NZF1-K33 diUb
  ----------------------------------------------------- ----------------------------------------------------------- -------------------------- --------------------------
  **Data Collection**                                                                                                                          
                                                                                                                                               
  Beamline                                              Diamond I03                                                 Diamond I24                Diamond I24
  Space group                                           *I* 4                                                       *P* 2~1~ 2~1~ 2~1~         *C* 2
  *a*, *b*, *c* (Å)                                     113.08, 113.08, 103.90                                      28.42, 42.48, 50.52        98.38, 126.51, 78.09
  α, β, γ (°)                                           90.00, 90.00, 90.00                                         90.00, 90.00, 90.00        90.00, 103.38, 90.00
  Wavelength                                            0.9763                                                      0.9686                     0.9686
  Resolution (Å)                                        45.47--1.85 (1.89--1.85)[a](#tblfn1){ref-type="table-fn"}   23.62--1.68 (1.72--1.68)   38.59--3.40 (3.67--3.40)
  *R*~merge~                                            4.5 (44.3)                                                  5.1 (77.6)                 10.9 (56.2)
  *I*/σ*I*                                              11.9 (2.5)                                                  19.9 (2.7)                 6.6 (2.0)
  Completeness (%)                                      99.8 (100)                                                  99.8 (99.5)                99.9 (100)
  Redundancy                                            3.5 (3.5)                                                   7.3 (7.7)                  3.4 (3.4)
                                                                                                                                               
  **Refinement**                                                                                                                               
                                                                                                                                               
  Resolution (Å)                                        45.47--1.85                                                 23.62--1.68                38.59--3.40
  No. of reflections                                    55,562                                                      7,363                      12,783
  *R*~work~/*R*~free~                                   22.9/27.1                                                   19.4/22.5                  18.0/22.2
                                                                                                                                               
  **No. of Atoms**                                                                                                                             
                                                                                                                                               
  Protein                                               4,788                                                       596                        4,076
  Ligand/ion                                            84                                                                                     5
  Water                                                 128                                                         49                         
                                                                                                                                               
  **B Factors**                                                                                                                                
                                                                                                                                               
  Wilson *B*                                            33.77                                                       26.49                      83.17
  Protein                                               70.20                                                       35.00                      106.68
  Ligand/ion                                            67.50                                                                                  83.84
  Water                                                 45.90                                                       43.17                      
                                                                                                                                               
  **RMSDs**                                                                                                                                    
                                                                                                                                               
  Bond lengths (Å)                                      0.005                                                       0.002                      0.002
  Bond angles (°)                                       0.930                                                       0.748                      0.603
  Ramachandran statistics (favored /allowed/outliers)   99.0/1.0/0.0                                                100.0/0.0/0.0              98.8/1.2/0.0

Numbers in brackets are for the highest-resolution bin.

[^1]: Co-first author
